"保持秘密":泄露的文件表明,菲利普莫里斯国际及其日本子公司继续利用科学获利
Sophie Braznell1, Louis Laurence1, Iona Fitzpatrick1
1Tobacco Control Research Group, Department for Health, University of Bath, Bath, UK.
概括
菲利普莫里斯国际 (PMI) 和其日本附属公司 (PMJ) 秘密资助研究并影响科学论领袖,反映了烟草行业过去的战术. 这破坏了PMI关于科学透明的说法,并引发了公众健康的担忧.
科学领域:
- 烟草行业的科学实践 烟草行业的科学实践
- 公共卫生研究诚信 公共卫生研究诚信
- 企业对科学的影响
背景情况:
- 烟草行业有着操纵科学来隐产品危害的历史.
- 菲利普·莫里斯国际 (PMI) 声称将进行"透明科学",作为其转型的一部分.
- 本研究使用泄露的文件检查了PMI及其日本附属公司菲利普·莫里斯日本 (PMJ) 的当代科学实践.
研究的目的:
- 评估PMI和PMJ是否采用已知的企业策略来影响科学以符合其利益.
- 检查PMI和PMJ的当代科学实践.
- 评估PMI关于进行"透明科学"的说法.
主要方法:
- 分析了PMI和PMJ (2012-2020) 泄露的24份文件.
- 将福斯特的解释学方法应用于公司文件的应用.
- 使用"科学为利"模式进行主题分析.
主要成果:
- 通过第三方组织 (CMIC),PMJ秘密资助了京都大学学者进行的戒烟研究.
- PMJ支付了一家咨询公司 (FTI-Innovations),与科学论领袖建立关系,并推广PMI的科学和产品.
- 这些活动类似于影响科学行为,出版和传播的策略,同时隐了行业的参与.
结论:
- PMI和PMJ最近的活动反映了烟草行业过去操纵科学的做法.
- 这些发现破坏了PMI宣称的转型及其对可信科学的断言.
- 迫切需要进行改革,以保护科学完整性免受烟草行业的既得利益的影响,特别是在日本等关键市场.
更多相关视频
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
12.2K
08:33Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies
Published on: April 12, 2022
3.5K
相关概念视频
MALDI-TOF Mass Spectrometry
5.8K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
5.8K
Censoring Survival Data
689
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
689
